Brain Alterations and Cognitive Impairment in Older Adults With Heart Failure

Sponsor
University of Wisconsin, Madison (Other)
Overall Status
Completed
CT.gov ID
NCT01821638
Collaborator
National Institutes of Health (NIH) (NIH)
40
1
69
0.6

Study Details

Study Description

Brief Summary

Cognitive impairment, commonly reported as difficulty with memory and executive function, is a widely recognized clinical challenge for older persons with heart failure (HF). Little is known about the relationship between brain MRI and cognitive impairment in older persons with HF. A limited number of studies have investigated brain MRI in adults with HF and produced conflicting results. Previous findings are limited by use of lower resolution scanners (1.5 Tesla), lack of MRI techniques (i.e. combining structural sequences with perfusion sequences) and recruitment of mixed age samples. Based on these limitations, the purpose of this research plan is to explore the relationship between brain MRI and cognitive impairment in older persons with HF using high resolution structural and perfusion scans. To accomplish this goal, investigators will compare 40 adults with HF who are age > 65 years old with 40 healthy, gender, age, and education matched controls. Investigators will obtain neuropsychological measures of multiple domains, as well as MRI measurements of the temporal lobe and prefrontal cortex at baseline and 12-months.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Cognitive impairment, commonly reported as difficulty with memory and executive function, is a widely recognized clinical challenge for persons > 65 years old with HF. Although the degree of cognitive impairment usually does not meet the criteria for dementia, it can affect an individual's ability to process and remember information, such as complex medication regimens [5]. Findings suggest that brain regions that support memory (i.e. temporal lobe) and executive function (i.e. prefrontal cortex) may be altered in older persons with HF; suggesting that these brain alterations are related to the HF disease process and not normal aging. Surprisingly, despite the high prevalence of cognitive impairment in HF, relationships between brain and cognition have not been well studied.

    Little is known about the relationships between brain magnetic resonance imaging (MRI) and cognitive impairment in older persons with HF. A limited number of studies have investigated brain MRI in adults with HF and produced conflicting results. Three studies utilized structural MRI techniques and identified evidence of atrophy in the temporal lobe, hippocampus, and prefrontal cortex and an increased volume of white matter hyperintensities [6-8]. Brain hypoperfusion, operationalized as decreased global cerebral perfusion, was identified in two studies [9, 10]. Only one study examined relationships between brain MRI and cognitive impairment in HF [6]. Vogels et al., (2007) found that atrophy in the medial temporal lobe was associated with decreased measures of memory and executive function. White matter hyperintensities did not correlate with any cognitive measures. Limited research findings indicate that various brain alterations in the temporal lobe, hippocampus, and prefrontal cortex contribute to cognitive impairment in HF. However, previous findings are limited by use of lower resolution scanners (1.5 Tesla), lack of MRI techniques (i.e. structural and perfusion scans) and recruitment of mixed age samples.

    Based on these limitations, the purpose of this research plan is to explore relationships between brain MRI and cognitive impairment in older persons with HF using high resolution structural and perfusion scans. To accomplish this goal, investigators will compare 40 adults with HF who are > 65 years old with 40 healthy, gender, age, and education matched controls. Investigators will obtain neuropsychological measures of multiple domains, as well as MRI measurements of the temporal lobe and prefrontal cortex at baseline and 12-months. The following specific aims will be investigated:

    Aim 1: Compare brain MRI in older persons with HF and controls at baseline and 12-months.

    Hypothesis 1a: Older persons with HF will have increased white matter hyperintensities, decreased grey matter volume, and decreased perfusion in the temporal lobe and prefrontal cortex compared with controls. Hypothesis 1b: Older persons with HF will exhibit a greater decline in grey matter volume in the temporal lobe and prefrontal cortex over 12-months compared with controls.

    Aim 2: Compare cognitive function in older persons with HF and controls at baseline and 12-months.

    Hypothesis 2a): Older persons with HF will perform lower on measures of memory and executive function compared with controls.

    Hypothesis 2b): Older persons with HF will exhibit a greater decline on measures of memory and executive function over 12-months compared with controls.

    Aim 3: Examine the relationships between brain MRI and cognitive function in older persons with HF and controls at baseline.

    Hypothesis 3a: Decreased grey matter and perfusion in the temporal lobe and an increased volume of white matter hyperintensities in the temporal lobe will be associated with decreased memory scores.

    Hypothesis 3b: Decreased grey matter and perfusion in the prefrontal cortex and an increased volume of white matter hyperintensities in the prefrontal cortex will be associated with a decreased executive function score.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    40 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Brain Alterations and Cognitive Impairment in Older Adults With Heart Failure
    Actual Study Start Date :
    Apr 1, 2013
    Actual Primary Completion Date :
    Dec 31, 2017
    Actual Study Completion Date :
    Dec 31, 2018

    Arms and Interventions

    Arm Intervention/Treatment
    Older adults with heart failure

    Older adults with heart failure

    Outcome Measures

    Primary Outcome Measures

    1. Mean neuropsychological test scores and brain changes [One year]

      Compare mean values of the following outcomes between older adults with heart failure and older adults without heart failure at baseline neuropsychological test scores brain medial temporal lobe volume brain frontal cortex volume brain medial temporal lobe perfusion brain frontal cortex perfusion Compare mean value changes in the following outcomes between baseline and one year in patients with heart failure: neuropsychological test scores brain medial temporal lobe volume brain frontal cortex volume brain medial temporal lobe perfusion brain frontal cortex perfusion

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    65 Years to 85 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • 65 years old or older

    • English speaking and writing;

    • Stable guideline based medication regimen for at least four weeks prior to enrollment

    • New York Heart Association classification I-IV

    Exclusion Criteria:
    • Mini-Mental Status Exam score equal to or less than 24;

    • Current diagnosis of neurological illnesses or movement disorders (e.g. Alzheimer's dementia, Parkinson's disease, Epilepsy);

    • History of substance abuse/treatment;

    • Untreated depression

    • History of stroke;

    • Hepatic insufficiency;

    • Severe renal failure;

    • Untreated anemia;

    • Left ventricular assist device;

    • History of the following within three months of study enrollment: acute myocardial infarction, unstable angina, coronary artery bypass surgery, percutaneous transluminal angioplasty, or biventricular pacemaker insertion;

    • History of implantable device (or other MRI contraindications).

    • Prisoners

    • Pregnancy

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Wisconsin Hospital and Clinics Madison Wisconsin United States 53792

    Sponsors and Collaborators

    • University of Wisconsin, Madison
    • National Institutes of Health (NIH)

    Investigators

    • Principal Investigator: Lisa C Bratzke, PhD, University of Wisconsin, Madison

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University of Wisconsin, Madison
    ClinicalTrials.gov Identifier:
    NCT01821638
    Other Study ID Numbers:
    • 2012-1064
    First Posted:
    Apr 1, 2013
    Last Update Posted:
    Feb 6, 2019
    Last Verified:
    Feb 1, 2019
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Keywords provided by University of Wisconsin, Madison
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 6, 2019